First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer

  title={First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer},
  author={D. Chapman and V. Poirier and D. Vulkan and K. Fitzgerald and G. Rubin and W. Hamilton and S. Duffy and Alan Hart Dawn Helena Matthias Chris Susan Sarah Angie Thomas Gulliford Rolfe Hohmann Repperday Sykes Tay and Alan Hart Dawn Helena Thomas Gulliford Rolfe and Alan Thomas and D. Gulliford and H. Rolfe and Matthias Chris Susan Sarah Hohmann Repperday Sykes Taylor and M. Hohmann and Chris Repperday and S. Sykes and Sarah Taylor and Angie James Sarah Helen Rob Craig Dawson Forbes Ryan Turner and Angie Craig and J. Dawson and Sarah Forbes and Helen Ryan and R. Turner and Mush Donna David Andrew Sara Ahmad Chung Graham Millar Taiyari and Mush Ahmad and D. Chung and D. Graham and A. Millar and Sara Taiyari and Claire Friedemann Fergus Shelley Zoe Brian Smith Gleeson Hayles Kaveney Nicholson and C. Smith and F. Gleeson and Shelley Hayles and Zoe Kaveney and B. Nicholson},
  journal={British Journal of Cancer},
  pages={722 - 729}
Background Patients with non-specific symptoms often experience longer times to diagnosis and poorer clinical outcomes than those with site-specific symptoms. This paper reports initial results from five multidisciplinary diagnostic centre (MDC) projects in England, piloting rapid referral for patients with non-specific symptoms. Methods The evaluation covered MDC activity from 1st December 2016 to 31st July 2018, with projects using a common dataset. Logistical regression analyses were… Expand
Describing the potential of non-specific symptoms-based pathways for diagnosing less common cancers.
A non-specific symptomatic referral route diagnoses a broad range of less common cancers, and can support primary care case management for patients with symptoms of possible cancer that do not qualify for a site-specific urgent referral. Expand
The impact of Covid-19 on patients with suspected cancer: An analysis of ED presentation and referrals to a quick diagnosis unit
The clinical patterns of presentation and diagnosis of the pandemic period suggested that mass media-generated mental and behavioral responses with distressing symptoms played a significant role in most of these patients. Expand
Conceptual Framework to Guide Early Diagnosis Programs for Symptomatic Cancer as Part of Global Cancer Control
It is proposed that decisions about early diagnosis programs should consider four interrelated components: the conduct of a needs assessment to identify the cancers that may benefit most from early diagnosis in the target population, the consideration of symptom epidemiology to inform prioritization within an intervention, factors influencing prompt help-seeking at individual and system level, and the evaluation of factors influencing the health systems’ capacity to promptly assess patients. Expand
Tumour markers with clinically controlled cut‐offs for suspected cancer
Analysis of the diagnostic accuracy of a panel of 11 circulating TMs with clinically controlled thresholds in the differentiation of cancer from nonmalignant diseases shows a potential clinical value in lung cancer. Expand


Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms
Differences in the diagnostic pathway show that patients with symptoms mirroring the MDC referral criteria could benefit from a new referral pathway. Expand
The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer
The protocol for the evaluation of a multidisciplinary diagnostic centre-based pathway for the investigation of ‘low-risk but not no-risk’ cancer symptoms called the Suspected CANcer (SCAN) pathway is reported. Expand
Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway; a retrospective cohort study
Deviations in basic biochemistry were associated with a higher probability of underlying cancer and could possibly raise the level of suspicion of malignancy among physicians and the prevalence of cancer matches that of another NSSC-CPP in Denmark. Expand
The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer–a cross-sectional study of patient characteristics and cancer probability
A strong association was found between GP-estimated cancer risk at referral and probability of cancer, and the GP’s gut feeling was a common reason for referral which proved to be a strong predictor of cancer. Expand
Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study
Analysis of population-level data from the English National Cancer Diagnosis Audit 2014 provides support for early diagnosis interventions targeting common cancer symptoms, countering concerns that they might be simply expediting the detection of advanced stage disease. Expand
A differentiated approach to referrals from general practice to support early cancer diagnosis – the Danish three-legged strategy
The organisation of the Danish three-legged strategy in diagnosing cancer is argued for and described, which includes urgent referral pathways for symptoms suspicious of a specific cancer, urgent referral to diagnostic centres when the authors need quick and profound evaluation of patients with nonspecific, serious symptoms and finally easy and fast access to ‘No-Yes-Clinics’ for cancer investigations for those patients with common symptoms. Expand
Symptom lead times in lung and colorectal cancers: what are the benefits of symptom-based approaches to early diagnosis?
In most cancer cases detected by a symptom-based programme, the symptoms are caused by cancer, but in a significant minority of cases cancer detection is serendipitous and experiences the benefits of a standard screening programme, a substantial mean lead time and a higher probability of early-stage diagnosis. Expand
Patient characteristics and cancer prevalence in the Danish cancer patient pathway for patients with serious non-specific symptoms and signs of cancer-A nationwide, population-based cohort study.
The prevalence of cancer in the NSSC-CPP was 11%, and the most common cancer diagnosis was breast cancer, hematopoietic and lymphoid cancer and malignant melanoma. Expand
Variation in Comorbidity and Clinical Management in Patients Newly Diagnosed with Lung Cancer in Four Scottish Centers
  • D. Grose, G. Devereux, +10 authors R. Milroy
  • Medicine
  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2011
This is the first study to identify nontumor factors independent of performance status that together limit the ability to deliver radical, possibly curative, therapy to the authors' lung cancer population and is believed to be the first to identify significant intercenter differences within Scotland. Expand
Variation in practice, comorbidity, and treatment in newly diagnosed lung cancer patients.
e12056 Background: Treatment and survival rates within Scotland for patients with lung cancer appear lower than in many other European countries with the 5-year survival being quoted as 5-6% comparedExpand